Jemincare focuses on developing diverse and differentiated products, including innovative small molecules and biologics, specialty traditional Chinese medicines, high-end generics, and reformulated medicines. At Jemincare, we integrate internal research and external collaborations with worldwide academic and industrial groups. We aim to deliver high quality, innovative medicines that are affordable and accessible to patients around the world. 

Established in 2018, our global R&D center based in Zhangjiang, Shanghai consists of three innovation institutes, supported by medical, regulatory, planning and operation groups. Our team of industry’s top professionals has brought together expertise in basic research, preclinical and clinical development, and regulatory affairs, developing a world-class organization backed up with comprehensive safety and quality systems.